Generalizing the 5/10/15 Rule for U.S. Drug Development, Or The Cycle of the New

"U.S. drug development cycle, which he says “always follows the 5/10/15 rule. For the first 5 years, companies hype new drugs; next 5 years all hidden side effects are exposed, leading to black-box warnings and class action lawsuits; in [the] last 5 years, the companies start dissing their own old drug as the patent runs … Continue reading Generalizing the 5/10/15 Rule for U.S. Drug Development, Or The Cycle of the New